Management is re-underwriting a specific asset or business at a value far above its cost, using fresh third-party marks
The model's full reasoning — Q4 2021 call → NOWe need answer YES/NO. Need analyze transcript. Need determine if management puts concrete externally-derived value on something company owns/controls, conveys value far above paid/carrying/current results imply. Transcript: Harrow Health Q4 2021. Management discusses record revenues, growth, AMP-100, MAQ-100, IOPIDINE etc, investments, Surface Opthalmics, Melt Pharmaceuticals. Need see if management values specific holding using outside reference. Key parts: Mark Baum mentions noncontrolling equity positions in companies originally founded as Harrow subsidiaries before deconsolidated. "For example, in a few months, we expect Surface Opthalmics to report data on a major chronic dry eye study. This was the first study of its kind to ever go head-to-head against the two category-leading FDA-approved products, a big study. Soon thereafter, we expect Melt Pharmaceuticals to report top line data on its MELT-300 clinical study." This is about future data, not valuation. Later analyst asks about Surface: "you mentioned that they're preparing for a Phase 2 readout, what would be the natural sort of pathway to full approval for Surface's products or product?" Mark: "the SURF-100 study is a readout for a seven-arm study in chronic dry eye... The study that Surface has undertaken is completely unique in that it is going head-to-head against the two largest products in that market that are FDA approved... And what I would suggest is the value of our interest in that company and the direction of the Phase 3 studies, the ultimate studies that the company does for approval will be determined by this readout. And we're really excited about this readout. And the readout is going to happen here very, very soon. And that will, I think, be a very interesting – of interest to a lot of big companies who are interested in the dry eye market. So, we're excited about it. It's not six months away. It's a couple of months away or sooner, and it's exciting." This is not valuing a specific stake with outside reference. It's about future clinical readout and interest from big companies, but no concrete value. Other mentions: "increasing the cash on our balance sheet to record levels, which we accomplished without diluting our shareholders and completing several transformative transactions" no specific valuation. "we continue to be on the hunt for additional M&A opportunities" no.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TTI | TETRA Technologies, Inc. | Q1 2024 | 2024-05-01 | A |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
TTI · Q1 2024 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies a specific asset: its holdings in Standard Lithium and Kodiak Gas Services (marketable securities worth slightly over $13 million, with total marketable securities around $30 million). It grounds the value in an external reference—the recent Kodiak acquisition of CSI Compressco, which made the stake “very favorable to TETRA,” plus Kodiak’s $2.5 billion market cap and strong trading volumes that allow quick, low-pressure monetization.
GPRE · Q4 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Todd Becker explicitly identifies the company's ethanol plants as the specific asset being valued. He states that a high-quality plant trades in the private market at $1.80–$2.00 per gallon (or $2–$2.50 to build from scratch), while the company's overall market cap and net debt imply a lower value for its ~950 million gallon capacity.
AFL · Q2 2023 → YESThe question is: Does management put a CONCRETE, EXTERNALLY-DERIVED VALUE ON SOMETHING THE COMPANY ALREADY OWNS OR CONTROLS, and convey that this value is far above what the company paid, carries it a...YES Management identifies the specific equity stake in Varagon Capital (a minority interest they already held) and grounds its value in the external transaction where Man Group is acquiring Varagon.